We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$18.7B
AUM Growth
+$1.36B
Cap. Flow
+$221M
Cap. Flow %
1.18%
Top 10 Hldgs %
25.29%
Holding
1,658
New
94
Increased
608
Reduced
275
Closed
90

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$68M
2
LIN icon
Linde
LIN
+$61M
3
EW icon
Edwards Lifesciences
EW
+$55.5M
4
IDXX icon
Idexx Laboratories
IDXX
+$46.4M
5
ARRY icon
Array Technologies
ARRY
+$45.8M

Sector Composition

Rank Sector Weight
1 Technology 30.65%
2 Healthcare 21.65%
3 Industrials 10.6%
4 Consumer Discretionary 9.49%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBOC icon
901
International Bancshares
IBOC
$4.57B
$685K ﹤0.01%
15,502
-2,500
-14% -$109K
NEU icon
902
NewMarket
NEU
$8.72B
$684K ﹤0.01%
1,700
+200
+13% +$78K
ADT icon
903
ADT
ADT
$5.46B
$682K ﹤0.01%
113,100
+81,000
+252% +$507K
FYBR
904
DELISTED
Frontier Communications
FYBR
$682K ﹤0.01%
36,600
MAC icon
905
Macerich
MAC
$6.99B
$682K ﹤0.01%
60,556
+21,400
+55% +$218K
ONB icon
906
Old National Bancorp
ONB
$10.4B
$682K ﹤0.01%
48,959
PRGO icon
907
Perrigo
PRGO
$1.78B
$682K ﹤0.01%
20,100
TPH
908
DELISTED
Tri Pointe Homes
TPH
$682K ﹤0.01%
20,755
NHI icon
909
National Health Investors
NHI
$3.5B
$679K ﹤0.01%
12,951
+100
+0.8% +$5.15K
RARE icon
910
Ultragenyx Pharmaceutical
RARE
$2.6B
$675K ﹤0.01%
14,623
-3,000
-17% -$139K
ROIV icon
911
Roivant Sciences
ROIV
$26.2B
$675K ﹤0.01%
67,000
+53,500
+396% +$479K
WIX icon
912
WIX.com
WIX
$3.35B
$675K ﹤0.01%
8,624
+835
+11% +$68.7K
ZION icon
913
Zions Bancorporation
ZION
$10.5B
$674K ﹤0.01%
25,100
AMBA icon
914
Ambarella
AMBA
$3.6B
$673K ﹤0.01%
8,044
-1,400
-15% -$102K
ICUI icon
915
ICU Medical
ICUI
$4.58B
$672K ﹤0.01%
3,772
AZTA icon
916
Azenta
AZTA
$1.49B
$671K ﹤0.01%
14,381
-6,300
-30% -$276K
SON icon
917
Sonoco
SON
$5.77B
$671K ﹤0.01%
11,367
AVNT icon
918
Avient
AVNT
$4.23B
$670K ﹤0.01%
16,381
WEN icon
919
Wendy's
WEN
$1.65B
$669K ﹤0.01%
30,757
TNET icon
920
TriNet
TNET
$3.22B
$668K ﹤0.01%
7,037
+300
+4% +$27.3K
VC icon
921
Visteon
VC
$2.86B
$668K ﹤0.01%
4,651
HOMB icon
922
Home BancShares
HOMB
$6.27B
$667K ﹤0.01%
29,255
UMBF icon
923
UMB Financial
UMBF
$11.5B
$666K ﹤0.01%
10,930
-500
-4% -$29.8K
HRI icon
924
Herc Holdings
HRI
$5.64B
$665K ﹤0.01%
4,858
NEOG icon
925
Neogen
NEOG
$2.59B
$665K ﹤0.01%
30,564
+13,200
+76% +$239K

Similar funds

Handelsbanken Fonder's Q2 2023 Portfolio in Review

As of Q2 2023, Handelsbanken Fonder held 1,658 positions worth $18.7B, up 7.9% from $17.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Handelsbanken Fonder's Q2 2023 filing shows 94 new, 608 increased, 275 reduced and 90 closed positions. Its largest new stake was Linde: 166,967 shares worth $63.6M. The largest sale was Berkshire Hathaway Class B, an estimated $98.4M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Handelsbanken Fonder's largest Q2 2023 buy was Linde: 166,967 shares worth $63.6M.
  • Handelsbanken Fonder added most to Microsoft in Q2 2023, an estimated $68M increase.
  • Handelsbanken Fonder's biggest Q2 2023 reduction was Alibaba, cutting an estimated $83.5M.
  • Handelsbanken Fonder fully exited Berkshire Hathaway Class B in Q2 2023, selling an estimated $98.4M.
  • Handelsbanken Fonder's ten largest holdings make up 25% of its $18.7B portfolio in Q2 2023.
  • Handelsbanken Fonder opened 94 new positions and closed 90 in Q2 2023.
  • Handelsbanken Fonder's portfolio value rose 7.9% quarter-over-quarter to $18.7B.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.